Download Rule file

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
59A-3.251 Hospital Reporting of Exposure to Selected Infectious Diseases.
The licensed facility shall establish a written policy and procedure for notifying EMTs, paramedics or their emergency medical
transportation service employer, or other persons known to have been exposed to a patient with a selected infectious disease while
transporting or treating an ill or injured patient to that licensed facility. Selected infectious diseases are defined as Acquired
Immunodeficiency Syndrome; anthrax; syphilis in an infectious stage; diphtheria; disseminated vaccinia; Hansen’s disease; hepatitis
A; hepatitis B; hepatitis non A, non B, Legionnaire’s disease; malaria; measles; meningococcal meningitis; plague; poliomyelitis,
psittacosis; pulmonary tuberculosis; Q fever; rabies; rubella; typhoid fever. Each licensed facility shall designate a person or persons
to notify the EMT’s, paramedics or their emergency medical transportation service employer or other persons known to have been
exposed to a patient with a selected infectious disease. These procedures shall include at a minimum the following:
(1) Notification of exposure to a selected infectious disease, either verbal or written, must take place within 48 hours of a confirmed
diagnosis.
(2) Verbal notification of such exposure to a selected infectious disease must be followed by written notification within 48 hours
of a confirmed diagnosis.
(3) Identification of EMT, paramedic, or other known persons to have been in contact with the patient during treatment or
transport, if notification is made to the EMS provider.
(4) Both written and verbal notification shall contain at a minimum:
(a) Name of disease;
(b) Signs and symptoms of clinical disease;
(c) Date of exposure to the selected infectious disease;
(d) Incubation period of disease;
(e) Mode of spread of the disease; and,
(f) Advisement of appropriate diagnosis, prophylaxis, and treatment, if any.
(5) Confidentiality of patient information must be maintained. The name of the patient shall not be disclosed.
Rulemaking Authority 395.1055 FS. Law Implemented 395.1025 FS. History–New 3-11-86, Formerly 10D-28.131, Amended 4-17-97, Formerly
59A-3.131.